Drug recall · February 1, 2017
Furosemide Tablets USP recall
Why: Failed Tablet/Capsule Specifications: An unusually thick tablet was reported through a complaint.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Furosemide Tablets USP, 20 mg, 1000 count bottles, Rx only, Roxane Laboratories, Inc., Columbus, Ohio 43216, NDC 0054-4297-31.
- Lots / codes
Lot# 660833A, Exp 08/31/18
- Quantity
- 6493 bottles
- Company
- Roxane Laboratories, Inc., Columbus, OH
- Distribution
- Nationwide in the USA
- Initiated
- December 22, 2016 · Voluntary: Firm initiated
- Classified
- January 23, 2017
- Reported
- February 1, 2017
- Ended
- December 18, 2017
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Furosemide
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.